Heier Jeffrey S. Insider Trades & Stock Holdings

Chief Scientific Officer · Ocular Therapeutix, Inc. · Latest filing Oct 2, 2026

Heier Jeffrey S., Chief Scientific Officer at Ocular Therapeutix, Inc. has 1 Form 4 trade on file since Oct 2, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($76.63K), net -$76.63K. Latest filing: disposed of 10.87K shares of $OCUL on Oct 2, 2026 at $7.05.

Trades on file

1

Open-market bought

$0

Open-market sold

$76.63K

Net open-market

-$76.63K

Latest filing

Oct 2, 2026

All insider trades by Heier Jeffrey S.

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 2, 2026	$OCUL	Sell (Open-market sale) 10b5-1	10.87K	$7.05	$76.63K			+8.3%			Chief Scientific Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Heier Jeffrey S. traded

• $OCUL

Frequently asked questions

Has Heier Jeffrey S. been buying or selling stock?

Heier Jeffrey S. has 0 open-market purchases and 1 open-market sale on file, net -$76.63K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Heier Jeffrey S.'s latest insider trade?

disposed of 10.87K shares of $OCUL on Oct 2, 2026 at $7.05.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.